Bristol-Myers Squibb (BMY)
Price/Share*: |
$31.90 |
Annualized Dividend: |
$1.36 |
Div. Yield: |
4.26% |
52-Week High: |
$35.44 |
% Off 52-Week High: |
-9.99% |
52-Week Low: |
$24.97 |
Recent/Upcoming Dividend Payouts for BMY
| Amount | Ex-Dividend Date | Record Date | Pay Date | Declare Date | Qualified? [?] | Type | |||
|---|---|---|---|---|---|---|---|---|---|
| BMY has not yet officially announced its next dividend payout. | |||||||||
| $0.34 | 1/4/2012 | 1/6/2012 | 2/1/2012 | 12/6/2011 | Yes | Regular | |||
| $0.33 | 10/6/2011 | 10/11/2011 | 11/1/2011 | 9/20/2011 | Yes | Regular | |||
| $0.33 | 6/29/2011 | 7/1/2011 | 8/1/2011 | 6/22/2011 | Yes | Regular | |||
| $0.33 | 3/30/2011 | 4/1/2011 | 5/2/2011 | 3/1/2011 | Yes | Regular | |||
View Historical Dividend Data for BMY »
Add BMY to My Watchlist »
DARS™ Stock Ratings for BMY
If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Bristol-Myers Squibb (BMY) in this space, including whether we think your should Buy, Hold, or Sell this stock.
Sign up for Dividend.com Premium today to gain access to ratings on nearly 1,600 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!
Subscribe to Dividend.com Premium Today! »
Recent Dividend.com Articles for BMY
- Feb 4, 2012This Week's Best & Worst Performing Analyst Upgrades - Feb.4 Edition
- Jan 30, 2012Bristol-Myers Still a "Buy" at Jefferies Despite Lower Price Target (BMY)
- Jan 28, 2012This Past Week's Earnings/Story Stocks Winners & Losers - Jan.28 Edition
- Jan 26, 2012Bristol-Myers Profit Surges 76%, but Still Misses View (BMY)
- Jan 14, 2012This Past Week's Earnings/Story Stocks Winners & Losers - Jan.14 Edition
- Jan 9, 2012Market Wrap-Up for Jan.9 (BMY, RL, BRCM, CME, COST, AFL, more)
- Jan 9, 2012Bristol Myers to Buy Hep C Treatment Maker Inhibitex for $2.5 Billion (BMY, INHX)
- Dec 6, 2011Dividend Payout Changes for Dec.6
- Oct 29, 2011This Past Week's Earnings/Story Stocks Winners & Losers - Oct.29 Edition
- Oct 29, 2011This Week's Best & Worst Performing Analyst Downgrades - Oct.29 Edition
Bristol-Myers Squibb (BMY) Company Profile
Bristol Myers Squibb Co. (BMY) is a global pharmaceuticals company. BMY engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and related healthcare products. Formerly known as Bristol-Myers Company, BMY was 1887 and is based in New York, New York.
* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.
** Under no circumstances does the information on this website represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.
*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.
FREE Dividend Stock Newsletter
Get the Dividend.com email newsletter to receive:
- A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
- Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
- Tons of great market analysis and recommendations
DIRECT COMPETITORS
RELATED COMPANIES
OFFERS FROM OUR SPONSORS
MORE RESEARCH
RSS Feeds